HAVCR2 in subcutaneous panniculitis‐like T cell lymphoma: comment on the article by Chambers et al
- 22 April 2026
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatology
- Vol. 78 (8) , 1808-1810
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Subcutaneous Panniculitis-like T-cell Lymphoma with Secondary Haemophagocytic Lymphohistiocytosis Arising at Widespread Tattoo Sites: A Case ReportActa Dermato-Venereologica, 2026
- Subcutaneous panniculitis-like T-cell lymphoma in a patient with dermatomyositis and rheumatoid arthritisScandinavian Journal of Rheumatology, 2025
- Clinical Images: Subcutaneous panniculitis‐like T cell lymphomaArthritis & Rheumatology, 2025
- Efficacy of ruxolitinib for HAVCR2 mutation‐associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in childrenBritish Journal of Haematology, 2023
- Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysisHaematologica, 2023
- Malignancy-associated haemophagocytic lymphohistiocytosisThe Lancet Haematology, 2022
- Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutationsBlood Advances, 2021
- TIM3 comes of age as an inhibitory receptorNature Reviews Immunology, 2019
- Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patientsJournal of the American Academy of Dermatology, 2018
- Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndromeNature Genetics, 2018